Fimbrion

Fimbrion Therapeutics, Inc. is a life sciences company headquartered in St. Louis, Missouri, founded in 2012 with intellectual property licensed from Washington University. Fimbrion's mission is to discover, develop, and commercialize first-in-class anti-infective drugs that are antibiotic-free for the prevention and treatment of bacterial infectious diseases, including those caused by antibiotic-resistant strains.